It wasn't all that long ago that CYPB said they would lay off a majority of their work force to cut annual costs.
http://finance.yahoo.com/news/Cypress-Bioscience-lays-off-apf-2921238166.html?x=0&.v=1
Then they turn around and do a few deals. Goodness. In one ear and out the other?
Prior to that, they discontinue their rights under their agreement with Forest Laboratories to co-promote Savella, yet they retain all other rights under that agreement with Forest, including its royalty on Savella sales? They note: Forest will maintain promotional levels behind Savella.
http://www.biospace.com/news_story.aspx?NewsEntityId=189648
SO Forest is still very involved with Savella, right? As is Cypress, correct?
I suppose I need to look at that agreement, for starters? To understand what the hell this means..."Forest has agreed to pay Cypress a one-time payment of $2.0 million to help facilitate with this transition"
The transition of no longer 'co promoting' Savella? Since Forest will maintain promotional levels behind Savella?
(I'm off on that part, aren't I? Starbucks time?)
A mind troubled by doubt cannot focus on the course to victory.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM